NCT04711954Unknown不适用
COVID-19 in People Living With HIV in Light of the 90-90-90 Goals: A Netherlands/Ukraine Research Collaboration.
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 1,100
- 试验地点
- 2
- 主要终点
- Prevalence COVID19
研究概览
简要总结
Contradicting preliminary results are available on the impact of COVID-19 in people with HIV (PWH). How achieving goals of the HIV 90-90-90 cascade of care influences the risk of COVID-19 in PWH is unclear. The primary objective is to determine the impact of COVID-19 in PWH cohorts from Ukraine and the Netherlands.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •HIV infected No registered objection to use of data
排除标准
- 未提供
结局指标
主要结局
Prevalence COVID19
时间窗: Up to 2 years
Prevalence (percent) of clinical COVID-19 in PWH cohorts from Ukraine and in the Netherlands.
次要结局
- Incidence COVID-19(Up to 2 years)
- WHO categories COVID-19(Up to 2 years)
- WHO disease severity COVID-19(Up to 2 years)
- Seroprevalence(Up to 2 years)
- NPV/PPV WHO categories COVID19(Up to 2 years)
- Treatment(Up to 2 years)
- Predictors for COVID-19 severity(Up to 2 years)
- Predictors for COVID-19(Up to 2 years)
研究者
Casper Rokx
MD PhD
Erasmus Medical Center
研究点 (2)
Loading locations...
相似试验
已完成
不适用
COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited SettingsHIV-infection/AidsCoronavirus InfectionNCT04371835Kirby Institute596
Unknown
不适用
Clinical Characterisation Protocol for COVID-19 in People Living With HIVAdult Patients Living With HIV (PLWHIV) With Confirmed Infection With SARS-CoV-2 Since 1st January 2020NCT04361604Assistance Publique - Hôpitaux de Paris270
Unknown
不适用
Immunogenicity of COVID-19 Vaccination in PLWHHIV InfectionsNCT04894448CIHR Canadian HIV Trials Network500
已完成
不适用
COVID-19 in Patients With HIVHIV/AIDSCOVID-19SARS-CoV-2NCT04333953University of Missouri-Columbia412
招募中
不适用
Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis).Covid19Immune SuppressionHIV-1-infectionNCT04526977Asociacion para el Estudio de las Enfermedades Infecciosas90